BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27444071)

  • 21. HRAS-related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects.
    Beyens A; Lietaer C; Claes K; De Baere E; Goeteyn M; Lerut B; Syryn H; Vanakker O; Van der Meulen J; Vanwalleghem L; Callewaert B
    Clin Genet; 2023 Jun; 103(6):709-713. PubMed ID: 36896710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phacomatosis Pigmentokeratotica: A Mosaic RASopathy with Malignant Potential.
    Om A; Cathey SS; Gathings RM; Hudspeth M; Lee JA; Marzolf S; Wine Lee L
    Pediatr Dermatol; 2017 May; 34(3):352-355. PubMed ID: 28523882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted resequencing of phosphorus metabolism‑related genes in 86 patients with hypophosphatemic rickets/osteomalacia.
    Gu J; Wang C; Zhang H; Yue H; Hu W; He J; Fu W; Zhang Z
    Int J Mol Med; 2018 Sep; 42(3):1603-1614. PubMed ID: 29901142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
    Fukumoto S
    Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RAS in FGF23: another piece in the puzzle.
    Ovejero D; Collins MT
    J Clin Endocrinol Metab; 2014 Jan; 99(1):63-6. PubMed ID: 24384015
    [No Abstract]   [Full Text] [Related]  

  • 26. Epidermal, sebaceous, and melanocytic nevoid proliferations are spectrums of mosaic RASopathies.
    Luo S; Tsao H
    J Invest Dermatol; 2014 Oct; 134(10):2493-2496. PubMed ID: 25219651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal nevus syndrome associated with adnexal tumors, spitz nevus, and hypophosphatemic vitamin D-resistant rickets.
    Kishida ES; Muniz Silva MA; da Costa Pereira F; Sanches JA; Sotto MN
    Pediatr Dermatol; 2005; 22(1):48-54. PubMed ID: 15660898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.
    Yamazaki Y; Okazaki R; Shibata M; Hasegawa Y; Satoh K; Tajima T; Takeuchi Y; Fujita T; Nakahara K; Yamashita T; Fukumoto S
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4957-60. PubMed ID: 12414858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary spastic paraplegia masqueraded by congenital melanocytic nevus syndrome: Dual pathogenesis of germline non-mosaicism and somatic mosaicism.
    Sakaguchi Y; Uehara T; Sasaki M; Fujimura K; Kishi K; Kosaki K; Takenouchi T
    Eur J Med Genet; 2020 Apr; 63(4):103803. PubMed ID: 31698101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burosumab for the treatment of cutaneous-skeletal hypophosphatemia syndrome.
    Abebe L; Phung K; Robinson ME; Waldner R; Carsen S; Smit K; Tice A; Lazier J; Armour C; Page M; Dover S; Rauch F; Koujok K; Ward LM
    Bone Rep; 2024 Mar; 20():101725. PubMed ID: 38229908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice.
    Aono Y; Hasegawa H; Yamazaki Y; Shimada T; Fujita T; Yamashita T; Fukumoto S
    J Bone Miner Res; 2011 Apr; 26(4):803-10. PubMed ID: 20939065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
    Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
    J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levels and dynamic changes of serum fibroblast growth factor 23 in hypophosphatemic rickets/osteomalacia.
    Xia WB; Jiang Y; Li M; Xing XP; Wang O; Hu YY; Zhang HB; Liu HC; Meng XW; Zhou XY
    Chin Med J (Engl); 2010 May; 123(9):1158-62. PubMed ID: 20529556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HRAS mutation mosaicism causing urothelial cancer and epidermal nevus.
    Hafner C; Toll A; Real FX
    N Engl J Med; 2011 Nov; 365(20):1940-2. PubMed ID: 22087699
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidermal nevus syndrome with hypophosphatemic rickets in a young girl.
    Sukkhojaiwaratkul D; Mahachoklertwattana P; Poomthavorn P
    J Paediatr Child Health; 2014 Jul; 50(7):566-9. PubMed ID: 24372733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRAF and NRAS mutations in melanoma and melanocytic nevi.
    Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
    Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases.
    Phadke PA; Rakheja D; Le LP; Selim MA; Kapur P; Davis A; Mihm MC; Hoang MP
    Am J Surg Pathol; 2011 May; 35(5):656-69. PubMed ID: 21436676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal nevus syndromes: New insights into whorls and swirls.
    Asch S; Sugarman JL
    Pediatr Dermatol; 2018 Jan; 35(1):21-29. PubMed ID: 29044700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna.
    Ward LM; Rauch F; White KE; Filler G; Matzinger MA; Letts M; Travers R; Econs MJ; Glorieux FH
    Bone; 2004 May; 34(5):905-11. PubMed ID: 15121023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations.
    Bauer J; Curtin JA; Pinkel D; Bastian BC
    J Invest Dermatol; 2007 Jan; 127(1):179-82. PubMed ID: 16888631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.